Digital Education

Home / Digital Education

Webinar

December 15, 2025

IMID & Obesity Boot Camp

Check out the 2025 IMID & Obesity Boot Camp.

FAQ

February 03, 2026

FAQ: Is Hypercortisolism a Common Condition?

This FAQ video features endocrinology David Doriguzzi, PA-C, discussing emerging data showing that cortisol excess frequently goes unrecognized in patients with insulin resistance, refractory hypertension, and unexplained weight gain. Drawing on recent clinical trial evidence, he explains why nearly one in four patients with treatment-resistant diabetes may have underlying hypercortisolism and how expanding our understanding beyond classic Cushing syndrome features can support earlier recognition and more effective treatment. Designed for APPs and clinicians managing complex metabolic disease. Thank you to Corcept Therapeutics for sponsoring this FAQ Video Module.

FAQ

February 03, 2026

FAQ: How Do You Use the Dexamethasone Suppression Test?

In this FAQ video, David Doriguzzi, PA-C, breaks down how to screen for hypercortisolism using the 1 mg dexamethasone suppression test (DST). He explains the physiology behind cortisol suppression, how to correctly interpret post-dexamethasone cortisol levels, and why results that appear “low” on lab reports may actually be abnormal. The discussion also reviews the value of measuring dexamethasone levels, ACTH, and DHEAS to help differentiate adrenal versus pituitary causes of cortisol excess. Designed for APPs and clinicians managing patients with difficult-to-treat type 2 diabetes and suspected hypercortisolism. Thank you to Corcept Therapeutics for sponsoring this FAQ Video Module.

FAQ

February 03, 2026

FAQ: Who Should Clinicians Be Screening For Hypercortisolism?

In this FAQ video, Amy Burmesch, PA-C, discusses which patients with type 2 diabetes should be screened for hypercortisolism. She outlines key high-risk subgroups, including younger patients without a family history of diabetes, individuals with difficult-to-control diabetes despite multiple therapies, and patients with low bone density or unusual fragility fractures. This practical overview helps clinicians narrow screening decisions and identify underlying cortisol excess that may be driving insulin resistance and poor glycemic control. Thank you to Corcept Therapeutics for sponsoring this FAQ Video Module.